NCT01251965 2025-06-08Phase l/II Study of Ruxolitinib for Acute LeukemiaM.D. Anderson Cancer CenterPhase 1/2 Terminated27 enrolled 6 charts
NCT01620216 2021-11-04Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous LeukemiaOHSU Knight Cancer InstitutePhase 2 Terminated12 enrolled 12 charts